<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ISOLYTE S IN DEXTROSE- dextrose, sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride injection, solution </strong><br>B. Braun Medical Inc.<br></p></div>
<h1>Isolyte<span class="Sup">®</span> S in 5% Dextrose<br>(Multi-Electrolyte Injection)</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_1d3ecd06-7eab-48ad-8292-a9c3f1d12832"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Each 100 mL of Isolyte<span class="Sup">®</span> S (Multi-Electrolyte Injection) in 5% Dextrose contains: <br>Hydrous Dextrose USP 5 g; Sodium Chloride USP 0.53 g<br>Sodium Gluconate USP 0.5 g; Sodium Acetate Trihydrate USP 0.37 g<br>Potassium Chloride USP 0.037 g<br>Magnesium Chloride Hexahydrate USP 0.03 g<br>Water for Injection USP qs<br>pH adjusted with Hydrochloric Acid NF<br>pH: 5.0 (4.0–6.0)    Calories per liter: 170<br>Calculated Osmolarity: 550 mOsmol/liter, hypertonic<br>Concentration of Electrolytes (mEq/liter): Sodium 140; Chloride 106<br>Acetate (CH<span class="Sub">3</span>COO<span class="Sup">−</span>) 27; Gluconate (HOCH<span class="Sub">2</span>(CHOH)<span class="Sub">4</span>COO<span class="Sup">−</span>) 23<br>Potassium 5; Magnesium 3</p>
<p>Isolyte<span class="Sup">®</span> S in 5% Dextrose is sterile, nonpyrogenic, and contains no bacteriostatic or antimicrobial agents or added buffers. This product is intended for intravenous administration in a single dose container.</p>
<p>The formulas of the active ingredients are:</p>
<table>
<col>
<col>
<col>
<thead><tr class="First Last">
<th align="center" valign="bottom">Ingredients </th>
<th align="center">Molecular Formula </th>
<th align="center">Molecular Weight</th>
</tr></thead>
<tbody>
<tr class="First">
<td> Sodium Acetate Trihydrate USP</td>
<td> CH<span class="Sub">3</span>COONa•3H<span class="Sub">2</span>O</td>
<td align="center"> 136.08</td>
</tr>
<tr>
<td> Sodium Chloride USP</td>
<td> NaCl</td>
<td align="center">   58.44</td>
</tr>
<tr>
<td> Potassium Chloride USP</td>
<td> KCl</td>
<td align="center">   74.55</td>
</tr>
<tr>
<td> Magnesium Chloride Hexahydrate USP</td>
<td> MgCl<span class="Sub">2</span>•6H<span class="Sub">2</span>O</td>
<td align="center"> 203.30</td>
</tr>
<tr>
<td> Hydrous Dextrose USP</td>
<td> <br><img alt="Hydrous Destrose USP Molecular Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3c12918e-d32f-4400-9af5-dfe90324d5e1&amp;name=isolyte-s-in-dextrose-in-excel-1.jpg"><p class="MultiMediaCaptionNotCentered"></p>
</td>
<td align="center"> 198.17</td>
</tr>
<tr class="Last">
<td> Sodium Gluconate USP</td>
<td> <br><img alt="Sodium Gluconate USP Molecular Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3c12918e-d32f-4400-9af5-dfe90324d5e1&amp;name=isolyte-s-in-dextrose-in-excel-2.jpg"><p class="MultiMediaCaptionNotCentered"></p>
<br>
</td>
<td align="center"> 218.14</td>
</tr>
</tbody>
</table>
<p>The EXCEL<span class="Sup">®</span> Container is Latex-free, PVC-free, and DEHP-free.</p>
<p>The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers. The solution contact layer is a rubberized copolymer of ethylene and propylene. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary. Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.</p>
<p>Addition of medication should be accomplished using complete aseptic technique.</p>
<p>The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication site. Refer to the <a href="#LINK_c3c220f4-ce04-4917-9264-f5c7cb4c71bb">Directions for Use</a> of the container.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="LINK_72e3b5d8-92e2-4fa3-9124-be913b12bf7a"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Isolyte<span class="Sup">®</span> S in 5% Dextrose provides electrolytes and calories, and is a source of water for hydration. It is capable of inducing <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span> depending on the clinical condition of the patient.</p>
<p>Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> in the regulation of the acid-base equilibrium of body fluid.</p>
<p>Potassium, the principal cation of intracellular fluid, participates in carbohydrate utilization and protein synthesis, and is critical in the regulation of nerve conduction and muscle contraction, particularly in the heart.</p>
<p>Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration.</p>
<p>Magnesium, a principal cation of soft tissue, is primarily involved in enzyme activity associated with the metabolism of carbohydrates and protein. Magnesium is also involved in neuromuscular <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>.</p>
<p>Gluconate and acetate are organic ions which are hydrogen ion acceptors and contribute <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> during the metabolism to <span class="product-label-link" type="condition" conceptid="4135927" conceptname="Carbon dioxide">carbon dioxide</span> and water, and in sufficient quantities may serve as alkalinizing agents.</p>
<p>Dextrose provides a source of calories. Dextrose is readily metabolized, may decrease losses of body protein and nitrogen, promotes glycogen deposition and decreases or prevents <span class="product-label-link" type="condition" conceptid="4101761" conceptname="Ketosis">ketosis</span> if sufficient doses are provided.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="LINK_36e61898-d1a3-4a19-94c3-8086bf0d0e33"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">This solution is indicated for use in adults as a source of electrolytes, calories and water for hydration, and as an alkalinizing agent.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="LINK_0caf03f5-7006-4f8f-b23f-d32aea1c0463"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Solutions containing dextrose may be contraindicated in patients with <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to corn products.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_d08a6b07-6b4c-4596-ba49-64871769fc63"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, <span class="product-label-link" type="condition" conceptid="4266976" conceptname="Overhydration">overhydration</span>, congested states or <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>. The risk of dilutional states is inversely proportional to the electrolyte concentration. The risk of solute overload causing congested states with peripheral and <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span> is directly proportional to the electrolyte concentration.</p>
<p>Solutions containing sodium ions should be used with great care, if at all, in patients with <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, severe <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>, and in clinical states in which there is <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">sodium retention</span> with <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>.</p>
<p>Solutions containing potassium ions should be used with great care, if at all, in patients with <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>, severe <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal failure</span>, and in conditions in which potassium retention is present.</p>
<p>In patients with diminished renal function, administration of solutions containing sodium or potassium ions may result in sodium or potassium retention.</p>
<p>Solutions containing acetate should be used with great care in patients with metabolic or <span class="product-label-link" type="condition" conceptid="4006309" conceptname="Respiratory alkalosis">respiratory alkalosis</span>. The administration of acetate or gluconate ions should be done with great care in those conditions in which there is an increased level or an impaired utilization of these ions, such as severe <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">hepatic insufficiency</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_26eaa79c-184b-4c10-8bd0-3ea48ea96c88"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="LINK_1739a744-5a85-40cb-b13f-f3116b13c6e6"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">This solution should be used with care in patients with <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span>, <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>, <span class="product-label-link" type="condition" conceptid="194406" conceptname="Urinary tract obstruction">urinary tract obstruction</span>, or impending or frank cardiac decompensation.</p>
<p>Extraordinary electrolyte losses such as may occur during protracted nasogastric suction, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> or <span class="product-label-link" type="condition" conceptid="4295370" conceptname="Gastrointestinal fistula">gastrointestinal fistula</span> drainage may necessitate additional electrolyte supplementation.</p>
<p>Additional essential electrolytes, minerals, and vitamins should be supplied as needed.</p>
<p>Care should be exercised in administering solutions containing sodium or potassium to patients with renal or cardiovascular insufficiency, with or without <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, particularly if they are postoperative or elderly.</p>
<p>Potassium therapy should be guided primarily by serial electrocardiograms, especially in patients receiving digitalis. Serum potassium levels are not necessarily indicative of tissue potassium levels.</p>
<p>Solutions containing potassium or magnesium should be used with caution in the presence of cardiac disease, particularly in the presence of <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disease</span>.</p>
<p>Solutions containing acetate or gluconate should be used with caution. Excess administration may result in <span class="product-label-link" type="condition" conceptid="4030381" conceptname="Metabolic alkalosis">metabolic alkalosis</span>.</p>
<p>Solutions containing dextrose should be used with caution in patients with overt or known <span class="product-label-link" type="condition" conceptid="44808385" conceptname="Pre-diabetes">subclinical diabetes</span> mellitus, or carbohydrate intolerance for any reason.</p>
<p>To minimize the risk of possible incompatibilities arising from mixing this solution with other additives that may be prescribed, the final infusate should be inspected for cloudiness or precipitation immediately after mixing, prior to administration, and periodically during administration.</p>
<p>Do not use plastic container in series connection.</p>
<p>If administration is controlled by a pumping device, care must be taken to discontinue pumping action before the container runs dry or <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span> may result. If administration is not controlled by a pumping device, refrain from applying excessive pressure (&gt;300mmHg) causing distortion to the container such as wringing or twisting.  Such handling could result in breakage of the container.</p>
<p>This solution is intended for intravenous administration using sterile equipment.</p>
<p>Use only if solution is clear and container and seals are intact.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="LINK_ee2dfc71-3809-430f-afde-fec75e726ac3"></a><a name="section-6.2"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Significant deviations from normal concentrations may require tailoring of the electrolyte pattern, in this or an alternative solution.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="LINK_9f534d5d-debe-486c-b47f-b1e3a4bb4229"></a><a name="section-6.3"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Sodium-containing solutions should be administered with caution to patients receiving corticosteroids or corticotropin, or to other salt-retaining patients.</p>
<p>Administration of barbiturates, narcotics, hypnotics, or systemic anesthetics should be adjusted with caution in patients also receiving magnesium-containing solutions because of an additive central depressive effect.</p>
<p>Parenteral magnesium should be administered with extreme caution to patients receiving digitalis preparations.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="LINK_930ad0b3-ccec-4c6a-92aa-a5993aa7fab8"></a><a name="section-6.4"></a><p></p>
<h2>Carcinogenesis, mutagenesis, impairment of fertility</h2>
<p class="First">Studies with Isolyte<span class="Sup">®</span> S (Multi-Electrolyte Injection) in 5% Dextrose have not been performed to evaluate carcinogenic potential, mutagenic potential, or effects on fertility.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="LINK_19c8c939-fd0b-463d-af46-30efe886b06d"></a><a name="section-6.5"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="LINK_fcdb4d80-ed36-4bab-8cdb-f2f60bfe41cc"></a><a name="section-6.5.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_34ca23d5-c634-47b0-81f1-8c2bb6bc3262"></a><a name="section-6.5.1.1"></a><p></p>
<h4>Pregnancy Category C</h4>
<p class="First">Animal reproduction studies have not been conducted with Isolyte<span class="Sup">®</span> S in 5% Dextrose. It is also not known whether Isolyte<span class="Sup">®</span> S in 5% Dextrose can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Isolyte<span class="Sup">®</span> S in 5% Dextrose should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="LINK_6605378d-b241-444a-85f0-d8599404c633"></a><a name="section-6.6"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Isolyte<span class="Sup">®</span> S (Multi-Electrolyte Injection) in 5% Dextrose is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="LINK_d682829d-71e7-429b-a249-2c28375994b5"></a><a name="section-6.7"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness of Isolyte<span class="Sup">®</span> S (Multi-Electrolyte Injection) in 5% Dextrose in pediatric patients have not been established by adequate and well controlled trials, however, the use of electrolyte and dextrose solutions in the pediatric population is referenced in the medical literature. The warnings, precautions and adverse reactions identified in the label copy should be observed in the pediatric population.</p>
<p>In very low birth weight infants, excessive or rapid administration of dextrose injection may result in increased serum <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span> and possible <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span>.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="LINK_6cb7c782-095d-4ba7-aeaa-97b91475c214"></a><a name="section-6.8"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of Isolyte<span class="Sup">®</span> S (Multi-Electrolyte Injection) in 5% Dextrose did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="LINK_c4b017e1-1739-4f03-a0c2-caef90eb41a9"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Reactions which may occur because of the solution or the technique of administration include febrile response, <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> at the site of injection, <span class="product-label-link" type="condition" conceptid="444247" conceptname="Venous thrombosis">venous thrombosis</span> or <span class="product-label-link" type="condition" conceptid="318174" conceptname="Phlebitis">phlebitis</span> extending from the site of injection, <span class="product-label-link" type="condition" conceptid="4295895" conceptname="Extravasation">extravasation</span> and <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span>.</p>
<p>Too rapid infusion of hypertonic solutions may cause local <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> and venous irritation. Rate of administration should be adjusted according to tolerance. </p>
<p>Use of the largest peripheral vein and a small bore needle is recommended.</p>
<p>Symptoms may result from an excess or deficit of one or more of the ions present in the solution; therefore, frequent monitoring of electrolyte levels is essential.</p>
<p><span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">Hypernatremia</span> may be associated with <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> and exacerbation of <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span> due to the retention of water, resulting in an expanded extracellular fluid volume.</p>
<p>Reactions reported with the use of potassium-containing solutions include <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span> and <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>. The signs and symptoms of potassium <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> include <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span> of the extremities, <span class="product-label-link" type="condition" conceptid="4290597" conceptname="Absent reflex">areflexia</span>, muscular or <span class="product-label-link" type="condition" conceptid="4275136" conceptname="Paralysis of diaphragm">respiratory paralysis</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">mental confusion</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="316135" conceptname="Atrioventricular block">heart block</span>, electrocardiographic abnormalities and <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">cardiac arrest</span>. Potassium deficits result in disruption of neuromuscular function, and intestinal <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span> and dilatation.</p>
<p>If infused in large amounts, chloride ions may cause a loss of <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> ions, resulting in an acidifying effect.</p>
<p>Abnormally high plasma levels of magnesium can result in <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">circulatory collapse</span>, and <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> of cardiac and central nervous system function. <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">Respiratory depression</span> is the most immediate threat to life.</p>
<p>Magnesium deficits can result in <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, hyperirritability and <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychotic</span> behavior.</p>
<p>The physician should also be alert to the possibility of adverse reactions to drug additives. Prescribing information for drug additives to be administered in this manner should be consulted.</p>
<p>If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="LINK_fe771f36-14d5-4113-a56d-073479e82d98"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">In the event of a fluid or solute overload during parenteral therapy, reevaluate the patient's condition, and institute appropriate corrective treatment.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="LINK_8b54a54f-62e3-4aa4-936c-2bf95bb86233"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">This solution is for intravenous use only.</p>
<p>Dosage is to be directed by a physician and is dependent upon age, weight, clinical condition of the patient and laboratory determinations. Frequent laboratory determinations and clinical evaluation are essential to monitor changes in blood glucose and electrolyte concentrations, and fluid and electrolyte balance during prolonged parenteral therapy.</p>
<p>When a hypertonic solution is to be administered peripherally, it should be slowly infused through a small bore needle, placed well within the lumen of a large vein to minimize venous irritation. Carefully avoid infiltration.</p>
<p>Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient.</p>
<p>The presence of magnesium ions in this solution should be considered when phosphate is present in the additive solution, in order to avoid precipitation.</p>
<p>Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_c3c220f4-ce04-4917-9264-f5c7cb4c71bb"></a><a name="section-9.1"></a><p></p>
<h2>Directions for Use of EXCEL<span class="Sup">®</span> Container</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_cb9ae3eb-221d-4581-9b38-ba4b80b0ee2a"></a><a name="section-9.1.1"></a><p></p>
<h3>To Open</h3>
<p class="First">Tear overwrap down at notch and remove solution container. Check for minute leaks by squeezing solution container firmly. If leaks are found, discard solution as <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired. If supplemental medication is desired, follow directions below before preparing for administration.</p>
<p>Before use, perform the following checks:</p>
<ul class="Disk">
<li>Inspect each container. Read the label. Ensure solution is the one ordered and is within the expiration date.
</li>
<li>Invert container and carefully inspect the solution in good light for cloudiness, haze, or particulate matter. Any container which is suspect should not be used.
</li>
<li>Use only if solution is clear and container and seals are intact.</li>
</ul>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_312266af-3c4e-42a0-912f-379f38bd142c"></a><a name="section-9.1.2"></a><p></p>
<h3>Preparation for Administration</h3>
<ol class="Arabic">
<li>Remove plastic protector from sterile set port at bottom of container.
</li>
<li>Attach administration set. Refer to complete directions accompanying set.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_d57f4888-e5b9-46cf-9e6f-f5881767afc5"></a><a name="section-9.1.3"></a><p></p>
<h3>To Add Medication Before Solution Administration</h3>
<ol class="Arabic">
<li>Prepare medication site.
</li>
<li>Using syringe with 18–22 gauge needle, puncture medication port and inner diaphragm and inject.
</li>
<li>Squeeze and tap ports while ports are upright and mix solution and medication thoroughly.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_9768596a-62df-4475-bb5d-e73777e3d594"></a><a name="section-9.1.4"></a><p></p>
<h3>To Add Medication During Solution Administration</h3>
<ol class="Arabic">
<li>Close clamp on the set.
</li>
<li>Prepare medication site.
</li>
<li>Using syringe with 18–22 gauge needle of appropriate length (at least 5/8 inch), puncture resealable medication port and inner diaphragm and inject.
</li>
<li>Remove container from IV pole and/or turn to an upright position.
</li>
<li>Evacuate both ports by tapping and squeezing them while container is in the upright position.
</li>
<li>Mix solution and medication thoroughly.
</li>
<li>Return container to in use position and continue administration.</li>
</ol>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_f511b945-acce-48c9-a5f1-85b26f980c5c"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Isolyte<span class="Sup">®</span> S (Multi-Electrolyte Injection) in 5% Dextrose is supplied sterile and nonpyrogenic in 1000 mL EXCEL<span class="Sup">®</span> Containers packaged 12 per case.</p>
<table>
<col>
<col>
<col>
<thead><tr class="First Last">
<th align="center">NDC</th>
<th align="center">Cat. No.</th>
<th align="center">Size</th>
</tr></thead>
<tbody>
<tr class="First">
<td align="center"> Isolyte<span class="Sup">®</span> S in 5% Dextrose<br>(Canada DIN 01935992)</td>
<td align="center"> </td>
<td align="center"> </td>
</tr>
<tr class="Last">
<td align="center"> 0264-7704-00</td>
<td align="center"> L7040</td>
<td align="center"> 1000 mL</td>
</tr>
</tbody>
</table>
<p>Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C).</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_b73f919e-ef88-4a41-9a12-4629e19e4331"></a><a name="section-11"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx only</span></p>
<p>Revised: December 2009</p>
<p>EXCEL and Isolyte are registered trademarks of B. Braun Medical Inc.</p>
<p><span class="Bold">B. Braun Medical Inc.</span><br>Irvine, CA 92614-5895 USA<br>Made in USA</p>
<p>In Canada, distributed by: <br><span class="Bold">B. Braun Medical Inc.<br></span>Scarborough, Ontario M1H 2W4</p>
<p>Y36-002-718</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_d540afd5-280a-4d8e-abdc-4fa3e171364e"></a><a name="section-12"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 1000 mL Container Label</h1>
<p class="First"><span class="Bold"> Isolyte® S in 5% Dextrose<br>(Multi-Electrolyte Injection)</span></p>
<p><span class="Bold">REF L7040<br>NDC 0264-7704-00<br>DIN 01935992</span></p>
<p><span class="Bold">1000 mL<br></span><span class="Italics">EXCEL® CONTAINER</span></p>
<p><span class="Bold">Electrolytes (mEq/liter):<br>Na<span class="Sup">+</span> . . . . . 140      Mg<span class="Sup">++ </span>. . . . 3       Acetate  . . . . .  27<br>K<span class="Sup">+</span> . . . . .    5         Cl<span class="Sup">-</span> . . . . 106      Gluconate . . .  23<br>Each 100 mL contains:<br>Hydrous Dextrose USP 5 g<br>Sodium Chloride USP 0.53 g<br>Sodium Gluconate USP 0.5 g<br>Sodium Acetate•3H<span class="Sub">2</span>O USP 0.37 g<br>Potassium Chloride USP 0.037 g<br>Magnesium Chloride•6H<span class="Sub">2</span>O USP 0.03 g<br>Water for Injection USP qs<br>pH adjusted with HCl NF<br><br>pH: 5.0 (4.0-6.0)<br>Calc. Osmolarity: 550 mOsmol/liter, hypertonic</span></p>
<p>Sterile, nonpyrogenic. Single dose container.</p>
<p>Do not use in series connection.<br>For intravenous use only. Use only if solution is clear and <br>container and seals are intact.</p>
<p><span class="Bold">WARNINGS:</span> Some additives may be incompatible. Consult <br>with pharmacist. When introducing additives, use aseptic <br>techniques. Mix thoroughly. Do not store.</p>
<p>Recommended Storage:<br>Room temperature (25ºC). Avoid excessive heat. Protect from <br>freezing. See Package Insert.<br><img alt="Latex free, DEHP free and PVC free" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3c12918e-d32f-4400-9af5-dfe90324d5e1&amp;name=isolyte-s-in-dextrose-in-excel-3.jpg"><p class="MultiMediaCaptionNotCentered"></p><br>Rx only<br><img alt="Other" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3c12918e-d32f-4400-9af5-dfe90324d5e1&amp;name=isolyte-s-in-dextrose-in-excel-4.jpg"><p class="MultiMediaCaptionNotCentered"></p><br>EXCEL and Isolyte are registered trademarks of B. Braun Medical Inc.</p>
<p><span class="Bold">B. Braun Medical Inc.<br></span>Irvine, CA 92614-5895 USA<br>1-800-227-2862<br><a href="#www.bbraun.comMade">www.bbraun.com</a><br>Made in USA</p>
<p>In Canada, distributed by:<br><span class="Bold">B. Braun Medical Inc.<br></span>Scarborough, Ontario M1H 2W4</p>
<p>Y94-003-043<br>LD-150-2</p>
<p>Do not remove overwrap until ready for use. After <br>removing the overwrap, check for minute leaks by <br>squeezing container firmly. If leaks are found, <br>discard solution as <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired.</p>
<p>EXP<br>LOT</p>
<div class="Figure">
<img alt="1000 mL Container Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3c12918e-d32f-4400-9af5-dfe90324d5e1&amp;name=isolyte-s-in-dextrose-in-excel-5.jpg"><p class="MultiMediaCaption"></p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ISOLYTE S IN DEXTROSE 		
					</strong><br><span class="contentTableReg">hydrous dextrose, sodium chloride, sodium gluconate, sodium acetate trihydrate, potassium chloride and magnesium chloride hexahydrate injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0264-7704</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DEXTROSE</strong> (DEXTROSE) </td>
<td class="formItem">DEXTROSE</td>
<td class="formItem">5 g  in 100 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (SODIUM CATION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">0.53 g  in 100 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM GLUCONATE</strong> (GLUCONIC ACID) </td>
<td class="formItem">GLUCONIC ACID</td>
<td class="formItem">0.5 g  in 100 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SODIUM ACETATE</strong> (ACETIC ACID) </td>
<td class="formItem">ACETIC ACID</td>
<td class="formItem">0.37 g  in 100 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM CHLORIDE</strong> (POTASSIUM CATION) </td>
<td class="formItem">POTASSIUM CHLORIDE</td>
<td class="formItem">0.037 g  in 100 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>MAGNESIUM CHLORIDE</strong> (MAGNESIUM CATION) </td>
<td class="formItem">MAGNESIUM CHLORIDE</td>
<td class="formItem">0.03 g  in 100 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYDROCHLORIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0264-7704-00</td>
<td class="formItem">12  in 1 CASE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1000 mL in 1 CONTAINER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA019843</td>
<td class="formItem">08/09/1993</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>B. Braun Medical Inc.
							(002397347)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 5/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>cb81fe4a-10a7-4e24-aa4f-b4315fcfe39b</div>
<div>Set id: 3c12918e-d32f-4400-9af5-dfe90324d5e1</div>
<div>Version: 2</div>
<div>Effective Time: 20120502</div>
</div>
</div> <div class="DistributorName">B. Braun Medical Inc.</div></p>
</body></html>
